Tiger Eye Capital’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-29,842
Closed -$702K 51
2021
Q4
$702K Hold
29,842
0.19% 30
2021
Q3
$654K Hold
29,842
0.26% 30
2021
Q2
$822K Hold
29,842
0.21% 35
2021
Q1
$788K Sell
29,842
-531,052
-95% -$14.5M 0.16% 39
2020
Q4
$16.7M Sell
560,894
-71,294
-11% -$2.11M 2.93% 10
2020
Q3
$19.6M Sell
632,188
-208,094
-25% -$5.63M 4.77% 10
2020
Q2
$18.8M Buy
840,282
+346,967
+70% +$7.84M 4.45% 10
2020
Q1
$10.2M Sell
493,315
-2,365,856
-83% -$47.4M 3.43% 8
2019
Q4
$48M Buy
2,859,171
+909,605
+47% +$15.3M 8.52% 2
2019
Q3
$32.9M Buy
1,949,566
+1,657,712
+568% +$27.5M 8.63% 2
2019
Q2
$4.49M Buy
+291,854
New +$4.07M 0.93% 22

Other funds holding CLVT

Tiger Eye Capital's CLVT Position: Q1 2022 in Review

Tiger Eye Capital sold out of Clarivate (CLVT) in Q1 2022, closing a stake of 29,842 shares — an estimated $702K sold.

Tiger Eye Capital first reported a position in CLVT in Q2 2019 and held it in 11 quarters. The position peaked at $48M in Q4 2019. 285 funds tracked by Wall St. Rank hold CLVT as of Q1 2022.

  • Tiger Eye Capital reported no remaining Clarivate position as of Q1 2022 after selling out during the quarter.
  • Tiger Eye Capital sold 29,842 Clarivate shares in Q1 2022, an estimated $702K.
  • Tiger Eye Capital first reported a position in Clarivate in Q2 2019 and held it in 11 quarters.
  • Tiger Eye Capital's Clarivate position peaked at $48M in Q4 2019.
  • 285 funds tracked by Wall St. Rank held Clarivate as of Q1 2022.

Based on Tiger Eye Capital's 13F filing for Q1 2022, filed 16 May 2022.